Literature DB >> 26997280

Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit.

Nicole A Crowley1, Daniel W Bloodgood1, J Andrew Hardaway2, Alexis M Kendra2, Jordan G McCall3, Ream Al-Hasani4, Nora M McCall2, Waylin Yu1, Zachary L Schools5, Michael J Krashes6, Bradford B Lowell7, Jennifer L Whistler8, Michael R Bruchas3, Thomas L Kash9.   

Abstract

Kappa opioid receptors (KORs) are involved in a variety of aversive behavioral states, including anxiety. To date, a circuit-based mechanism for KOR-driven anxiety has not been described. Here, we show that activation of KORs inhibits glutamate release from basolateral amygdala (BLA) inputs to the bed nucleus of the stria terminalis (BNST) and occludes the anxiolytic phenotype seen with optogenetic activation of BLA-BNST projections. In addition, deletion of KORs from amygdala neurons results in an anxiolytic phenotype. Furthermore, we identify a frequency-dependent, optically evoked local dynorphin-induced heterosynaptic plasticity of glutamate inputs in the BNST. We also find that there is cell type specificity to the KOR modulation of the BLA-BNST input with greater KOR-mediated inhibition of BLA dynorphin-expressing neurons. Collectively, these results provide support for a model in which local dynorphin release can inhibit an anxiolytic pathway, providing a discrete therapeutic target for the treatment of anxiety disorders.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26997280      PMCID: PMC4814306          DOI: 10.1016/j.celrep.2016.02.069

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  49 in total

Review 1.  Topography of projections from amygdala to bed nuclei of the stria terminalis.

Authors:  H W Dong; G D Petrovich; L W Swanson
Journal:  Brain Res Brain Res Rev       Date:  2001-12

2.  Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex.

Authors:  Adena L Svingos; Eric E O Colago
Journal:  Brain Res       Date:  2002-08-16       Impact factor: 3.252

3.  Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms.

Authors:  Gregory O Hjelmstad; Howard L Fields
Journal:  J Neurophysiol       Date:  2003-05       Impact factor: 2.714

Review 4.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

5.  Opioids induce dissociable forms of long-term depression of excitatory inputs to the dorsal striatum.

Authors:  Brady K Atwood; David A Kupferschmidt; David M Lovinger
Journal:  Nat Neurosci       Date:  2014-02-23       Impact factor: 24.884

Review 6.  Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.

Authors:  Nicole A Crowley; Thomas L Kash
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-01-12       Impact factor: 5.067

7.  Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward.

Authors:  Ream Al-Hasani; Jordan G McCall; Gunchul Shin; Adrian M Gomez; Gavin P Schmitz; Julio M Bernardi; Chang-O Pyo; Sung Il Park; Catherine M Marcinkiewcz; Nicole A Crowley; Michael J Krashes; Bradford B Lowell; Thomas L Kash; John A Rogers; Michael R Bruchas
Journal:  Neuron       Date:  2015-09-02       Impact factor: 17.173

8.  Distribution of AMPA receptor subunit glur1 in the bed nucleus of the stria terminalis and effect of stress.

Authors:  George W Hubert; E Chris Muly
Journal:  Synapse       Date:  2014-02-03       Impact factor: 2.562

Review 9.  The epidemiology of anxiety disorders: prevalence and societal costs.

Authors:  Jean-Pierre Lépine
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

10.  NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking.

Authors:  Kristen E Pleil; Jennifer A Rinker; Emily G Lowery-Gionta; Christopher M Mazzone; Nora M McCall; Alexis M Kendra; David P Olson; Bradford B Lowell; Kathleen A Grant; Todd E Thiele; Thomas L Kash
Journal:  Nat Neurosci       Date:  2015-03-09       Impact factor: 24.884

View more
  59 in total

1.  Chronic stress dysregulates amygdalar output to the prefrontal cortex.

Authors:  Emily G Lowery-Gionta; Nicole A Crowley; Olena Bukalo; Shana Silverstein; Andrew Holmes; Thomas Louis Kash
Journal:  Neuropharmacology       Date:  2018-06-28       Impact factor: 5.250

2.  mTORC1 pathway is involved in the kappa opioid receptor activation-induced increase in excessive alcohol drinking in mice.

Authors:  Yan Zhou; Yupu Liang; Mary Jeanne Kreek
Journal:  Pharmacol Biochem Behav       Date:  2020-05-26       Impact factor: 3.533

3.  A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety.

Authors:  Matthew B Pomrenze; Jorge Tovar-Diaz; Angelo Blasio; Rajani Maiya; Simone M Giovanetti; Kelly Lei; Hitoshi Morikawa; F Woodward Hopf; Robert O Messing
Journal:  J Neurosci       Date:  2018-12-10       Impact factor: 6.167

4.  α2A-adrenergic heteroreceptors are required for stress-induced reinstatement of cocaine conditioned place preference.

Authors:  Rafael E Perez; Aakash Basu; Bretton P Nabit; Nicholas A Harris; Oakleigh M Folkes; Sachin Patel; Ralf Gilsbach; Lutz Hein; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2020-02-19       Impact factor: 7.853

5.  A Central Extended Amygdala Circuit That Modulates Anxiety.

Authors:  Sandra Ahrens; Melody V Wu; Alessandro Furlan; Ga-Ram Hwang; Raehum Paik; Haohong Li; Mario A Penzo; Jessica Tollkuhn; Bo Li
Journal:  J Neurosci       Date:  2018-05-29       Impact factor: 6.167

6.  Chronic ethanol exposure increases inhibition of optically targeted phasic dopamine release in the nucleus accumbens core and medial shell ex vivo.

Authors:  James R Melchior; Sara R Jones
Journal:  Mol Cell Neurosci       Date:  2017-09-20       Impact factor: 4.314

Review 7.  The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?

Authors:  Matthew B Pomrenze; Tracy L Fetterly; Danny G Winder; Robert O Messing
Journal:  Alcohol Clin Exp Res       Date:  2017-10-25       Impact factor: 3.455

8.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

9.  Reversal of a Treatment-Resistant, Depression-Related Brain State with the Kv7 Channel Opener Retigabine.

Authors:  Mengyang Feng; Nicole A Crowley; Akshilkumar Patel; Yao Guo; Sierra E Bugni; Bernhard Luscher
Journal:  Neuroscience       Date:  2019-03-08       Impact factor: 3.590

10.  Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.

Authors:  Chloe M Erikson; Gengze Wei; Brendan M Walker
Journal:  Neuropharmacology       Date:  2018-07-31       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.